The Medical Imaging & Technology Alliance (MITA) today applauded Reps. Charles Boustany, Jr. MD (R-La.), John Barrow (D-Ga.), Jim Renacci (R-Ohio) and Richard E. Neal (D-Mass.) for their leadership in advocating for Medicare coverage of low-dose computed tomography (LDCT) for patients at high risk of lung cancer. 

The (MC)2 risk score is a valuable tool for predicting major complications in patients undergoing renal cryoablation, according to a study published online May 7 by Radiology.

A recently published study has confirmed that MR-guided focused ultrasound (US) can relieve pain and improve function in most patients with bone tumors who are not candidates for radiation treatment.

Providers worldwide now have access to the American College of Radiology (ACR) Lung Imaging Reporting and Data System (Lung-RADS®) – a quality assurance tool to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring.

The American Society for Radiation Oncology (ASTRO) is concerned by the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) April 30, 2014 recommendation to the Centers for Medicare and Medicaid Services (CMS) that adults at high risk for lung cancer should not receive Medicare coverage of annual, low-dose computed tomography (LDCT) screening.

When the U.S. Preventive Services Task Force (USPSTF) recommended last December that annual screening with low dose CT (LDCT) be provided to asymptomatic adults aged 55-80 who had a 30 pack-year history of smoking, it seemed like the first step toward full national coverage of LDCT screening.

The Medicare Evidence Development & Coverage Advisory Committee (MedCAC) convened today and representatives from organizations such as the American College of Radiology and the Lung Cancer Alliance went before the committee to contend for national Medicare coverage of low dose CT (LDCT) screening for patients who are at a high risk for lung cancer.

Mark your calendars for Wednesday, April 30. That’s the day that representatives from the American College of Radiology, the Lung Cancer Alliance and a number of other organizations will go before the 2014 Medicare Evidence Development and Coverage Advisory Committee seeking to make the case for national Medicare coverage of low dose CT screening for patients at high risk for lung cancer.